Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Clinical trial NCT06218303 · RECRUITING
Trial details
- NCT number
- NCT06218303
- Sponsor
- Finn, Olivera, PhD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-07
- Primary completion
- 2028-02-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.